797 (Divalproex sodium delayed-release 250 mg)

Pill imprint 797 has been identified as Divalproex sodium delayed-release 250 mg.

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Divalproex sodium delayed-release

Imprint:

797

Strength:

250 mg

Color:

Orange

Size:

15.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Manufacturer:

Sun Pharmaceuticals

National Drug Code (NDC):

62756-0797

Inactive Ingredients:

silicon dioxide
corn starch
povidone k30
hypromellose
titanium dioxide
triacetin
methacrylic acid - ethyl acrylate copolymer (1:1) type a
magnesium silicate
triethyl citrate
sodium bicarbonate
sodium lauryl sulfate
FD&C Yellow No. 6
ferric oxide yellow

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
16590-0809	Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.